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Aims The impact of suicide loss on family members’ cardiometabolic health has little been evaluated in middle-aged and eld-
erly people. We investigated the effect of suicide loss on risks for cardiovascular disease (CVD) and diabetes mellitus
(DM) in suicide completers’ family members using a national representative comparison group.
Methods
and results
The study subjects were 4253 family members of suicide completers and 9467 non-bereaved family members of
individuals who were age and gender matched with the suicide completers in the Republic of Korea. National health
insurance data were used to identify medical care utilization during the year before and after a suicide loss. A recurrent-
events survival analysis was performed to estimate the hazard ratios (HRs) of hospitalizations for CVD, DM, or psychi-
atric disorders, after adjusting for age, residence, and socioeconomic status. Among subjects without a past history of
CVD, DM, or psychiatric disorders, the increased risks of recurrent hospitalizations were observed for CVD [HR 1.343,
95% confidence interval (CI) 1.001–1.800 in men; HR 1.240, 95% CI 1.025–1.500 in women] and DM (HR 2.238, 95%
CI 1.379–3.362 in men; HR 1.786, 95% CI 1.263–2.527 in women). In subjects with a past history of CVD, DM, or
psychiatric disorders, the number of medical care visits decreased after a suicide loss, and suicide completers’ family
members showed lower rates of hospitalization for CVD and DM than the comparison group.
Conclusion Compared with non-bereaved family members, suicide completers’ family members without a past history of CVD,
DM, or psychiatric disorder showed a high risk of hospitalization for those conditions.
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Introduction
The World Health Organization (WHO) estimates that ap-
proximately one million people die by suicide each year.1 There
are approximately half a million suicides in Asia, resulting in12 mil-
lion family members experiencing loss and grief.2 In the Republic of
Korea, the number of family members of suicide completers has
been estimated at 0.1 million (or six per suicide) in 2010.3,4 Suicide
is a major public health challenge because, in addition to the loss
of the deceased, it has adverse effects on family members. Com-
pared with typical bereaved or non-bereaved individuals, family
members of suicide completers are more likely to suffer from
mental illnesses such as depression,5,6 anxiety,7 suicide ideation,5
and suicidal behaviour.8,9
Although research has focused on the mental health of children
and adolescents,6 – 8 little is known about the resulting physical ill-
nesses in middle-aged and elderly family members of suicide com-
pleters. Some studies have shown that bereaved people have a
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greater number of medical care visits after a loss than the non-
bereaved,10,11 whereas others have reported no differences.12,13
The sample size, study period, and cause of the loss could be related
to this discrepancy. However, the number of medical care visits is
likely affected by having a past history of chronic illnesses, which
has not been considered in the literature.
Previous studies have suggested that psychological stress resulting
from family-member loss increases risk of cardiovascular disease
(CVD)14,15 and diabetes mellitus (DM).16 Suicide loss might also
cause severe psychological stress among family members, and the
adverse effects of that stress might be stronger than those ex-
perienced by individuals in typical bereavement (i.e. not a result of
suicide) due to social isolation and stigma.17 Severe psychological
stress may cause deterioration in physical health, especially in the
middle-aged and elderly. Consequently, there might be an increase
in the incidence of CVD and DM. However, to the best of our
knowledge, the risks for developing CVD and DM in suicide comple-
ters’ family members have not been investigated. In the current
study, we investigated changes in medical care utilization after sui-
cide loss and the effect of suicide loss on the risk for acute hospital-
ization for CVD and DM among the family members of suicide
completers, using a nationally representative comparison group.
Methods
Study subjects
We used a three-stage process to select subjects: (i) identification of
suicide completers, (ii) selection of individuals who were age and
gender matched with suicide completers, and (iii) identification of family
members of both suicide completers and matched individuals (Figure 1).
Suicide cases from 2002 (n ¼ 8631) and 2003 (n ¼ 10 932) were
identified from death statistics of the National Statistical Office. The
Republic of Korea has adopted a national health insurance system
based on a family, consisting of a subscriber and financially dependent
family members (i.e. the subscriber’s lineal ancestor, spouse, lineal
descendant, or sibling). Thus, family members of each suicide completer
could be identified through data from the Health Insurance Review and
Services Agency (HIRA). After excluding individuals with no family
identification information and with family members who had committed
suicide together (n ¼ 10), 4582 (1997 in 2002 and 2585 in 2003) sui-
cides were selected; the average age and the proportion of men were
similar to those of all suicide completers in 2002–2003.
To compare physical and mental illnesses in the family members of
suicide completers with that in the general population, we randomly se-
lected two individuals who were age and gender matched with each sui-
cide (n ¼ 9164) from among Korean health insurance subscribers and
their dependents in the relevant year. After excluding one-person (i.e.
suicide completer or matched individual) families, 3611 families of sui-
cide completers and 7815 matched families were selected. The family
members of each subject were identified using data from HIRA, and
9155 subjects among family members of suicide completers and
22 250 subjects among non-bereaved family members were selected.
We restricted the analysis to individuals who were ≥40 years of age be-
cause hospitalization for CVD and DM in those ,40 years is rare. Thus,
4253 family members of suicide completers and 9467 non-bereaved
family members were included in the final analysis (see Supplementary
material online, Table S1). This study was approved by the Institutional
Review Board of Yonsei University Health System (approval number
4-2011-0273), Seoul, Republic of Korea.
Medical care utilization
Medical care visit data of all Koreans, which includes age, gender, health
insurance premiums, family identification number, and diagnosis code
according to the International Statistical Classification of Diseases and
Related Health Problems, 10th revision (ICD-10), are typically reviewed
by the HIRA. Inpatient and outpatient medical care visits for CVD
[ischaemic heart disease (ICD-10 code: I20-I25), stroke (I60-I69),
hypertensive disease (I10-I15)], DM (E10-E14), and psychiatric disor-
ders (F00-F99) during the year before and after a suicide loss were iden-
tified. Medical care visits in the non-bereaved group were based on the
date of each matched suicide. A past history was defined as any medical
care visit for CVD, DM, or psychiatric disorders during a 1-year
period before a suicide loss. Deaths among the study population were
identified from death statistics of the National Statistical Office.
Statistical analysis
We divided the study population according to potential factors affecting
medical care utilization a priori, as follows: gender and past history of
CVD, DM, or psychiatric disorders. Because CVD, DM, and psychiatric
disorders are chronic illnesses requiring regular follow-up, past history
of medical care visits for CVD, DM, or psychiatric disorders was thought
to change the baseline likelihood of hospitalization for those conditions.
In addition, the likelihood of medical care utilization varies across gender
in the Republic of Korea.18 Thus, all analyses were performed separately,
according to whether a subject had a past history of CVD, DM, or psy-
chiatric disorders, and by gender.
Determination of socioeconomic status was based on health insur-
ance premium, which is based on family income and immovable prop-
erty; socioeconomic status was then categorized into quartiles.
Beneficiaries of the Medical Aid Programme were assigned to quartile
1. Area of residence was classified as metropolitan, urban, or rural.
In the survival analysis, hospital admissions for CVD, DM, and psychi-
atric disorders during the year after a suicide loss were considered.
A Cox proportional hazard model was used to estimate the hazard
ratios (HRs) and the 95% confidence intervals (CIs), after adjusting
for age, residence, and socioeconomic status. Because hospitalization
for each subject was a multiple and ordered event (see Supplementary
material online, Tables S2 and S3), a recurrent-events survival analysis
was performed with a Prentice– Williams –Peterson (PWP) total
time model,19 which is one of the stratified Cox proportional hazard
models; the first event was also analysed using a Cox proportional
hazards model. Because we used a family-based sampling method
and there may be a contextual effect of family, the identification
number of each family was included as a random effect in all the
Cox proportional hazards models.
All analyses were performed using SAS version 9.3 (SAS Institute,
Cary, NC, USA) and using randomly generated identification numbers
to mask the identities of the subjects. During the analysis, we checked
for violations of the assumptions of the proportional hazard models,
by incorporating interaction terms between each variable and time;
none were significant for all variables.
Results
The characteristics of the suicide completers’ family members and
the comparison group are presented in Table 1. Among subjects
without a past history of CVD, DM, or psychiatric disorders, suicide
completers’ family members consisted of 1586 men and 2373 wo-
men, and the comparison group consisted of 2677 men and 4285
women.
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An increase in the number of total medical care visits after suicide
loss was observed in individuals without a past history of CVD, DM,
or psychiatric disorders, while a decrease among those with a past
history (Table 2). In non-bereaved family members, the median
(interquartile) values of the number of medical care visits in those
without a past history of CVD, DM, or psychiatric disorders were
6.0 (8.0212.0) in men and 8.0 (3.0215.0) in women (data not
shown), which were higher than those of suicide completers’ family
members.
The proportion of patients hospitalized for CVD, DM, or psychi-
atric disorders was higher in suicide completers’ family members
compared with non-bereaved family members in those without a
past history of those illnesses (see Supplementary material online,
Table S2).
In the recurrent-events survival analysis, among subjects without
past history of CVD, DM, or psychiatric disorders, suicide comple-
ters’ family members were at an increased risk of hospitalization for
CVD within the year following a suicide loss, when compared with
non-bereaved individuals (HRs 1.34 and 1.24; 95% CI 1.00–1.80 and
1.03–1.50 for men and women, respectively) (Table 3). A decreased
risk was observed among those with a past history of CVD, DM, or
psychiatric disorders (HRs 0.54 and 0.53; 95% CI 0.38–0.76 and
0.41–0.68 for men and women, respectively). Among those without
a past history of CVD, DM, or psychiatric disorders, the HRs of hos-
pitalization for DM and psychiatric disorders increased significantly
after a suicide loss for both genders. Among those with a past his-
tory, only the risk of hospitalization for DM decreased significantly.
We checked the interactive effects of past history of CVD, DM,
or psychiatric disorders on the association between suicide loss and
hospitalization for those illnesses. All interaction terms were statis-
tically significant, with the exception of psychiatric hospitalization in
women (P, 0.001 for CVD and DM hospitalization in both gen-
ders; P ¼ 0.024 and P ¼ 0.248 for psychiatric admission in men
and women, respectively).
Discussion
Summary
In the present study, among those without a past history of CVD,
DM, or psychiatric disorders, we found that (i) although the number
of medical care visits increased after suicide loss, suicide completers’
Figure 1 Flow chart of study subjects selection. CVD, cardiovascular disease; DM, diabetes mellitus.
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family members sought medical care less frequently than did
non-bereaved family members; and (ii) suicide loss significantly in-
creased the risk of acute hospitalization for these disorders. In add-
ition, among those with a past history of CVD, DM, or psychiatric
disorders, the number of medical care visits decreased after suicide
loss, and both the number of medical care visits and the risk of hospi-
talization were lower compared with the non-bereaved. Several pre-
vious studies have reported that bereaved family members seek
medical care more frequently than do the non-bereaved,10,11 which
is opposite of the results of our study. Although we cannot fully explain
this discrepancy due to observational nature of our study, the possible
explanation is the effect of stigma on family members’ medical care
utilization via social isolation,17 which might be unique to Asians.
Cardiovascular disease
Compared with non-bereaved family members, the risk of hospital-
ization for CVD among suicide completers’ family members without
a past history of CVD, DM, or psychiatric disorder was increased by
34 and 24% in men and women, respectively, after a suicide loss. Sui-
cide loss causes severe psychological stress, which might result in
the development and exacerbation of CVD through elevation of
catecholamine and cortisol levels,20,21 as well as through changes
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Table 1 Baseline characteristics of suicide completers’ family members and non-bereaved family members, separated
by a past history of cardiovascular disease, diabetes mellitus, or psychiatric disorders
Without a past history of CVD, DM, or psychiatric
disorders
With a past history of CVD, DM, or psychiatric
disorders
Suicide completers’
family members
Non-bereaved family
members
P-valuea Suicide completers’
family members
Non-bereaved family
members
P-valuea
Men, n (%) 1586 2677 119 778
Age (years)
40–49 582 (36.7) 1050 (39.2) 0.255 18 (15.1) 169 (21.7) 0.237
50–64 591 (37.3) 964 (36.0) 53 (44.5) 332 (42.7)
≥65 413 (26.0) 663 (24.8) 48 (40.3) 277 (35.6)
Area of residence
Metropolitan 1402 (88.4) 1317 (49.2) ,0.001 101 (84.9) 388 (49.9) ,0.001
Urban 158 (10.0) 1047 (39.1) 14 (11.8) 287 (36.9)
Rural 26 (1.6) 313 (11.7) 4 (3.4) 103 (13.2)
Socioeconomic statusb
Quartile 1 72 (4.5) 125 (4.7) 0.516 10 (8.4) 42 (5.4) 0.424
Quartile 2 763 (48.1) 1348 (50.4) 54 (45.4) 352 (45.2)
Quartile 3 261 (16.5) 420 (15.7) 22 (18.5) 127 (16.3)
Quartile 4 490 (30.9) 784 (29.3) 33 (27.7) 257 (33.0)
Women, n (%) 2373 4285 175 1727
Age (years)
40–49 737 (31.1) 1741 (40.6) ,0.001 24 (13.7) 262 (15.2) 0.235
50–64 958 (40.4) 1524 (35.6) 63 (36.0) 712 (41.2)
≥65 678 (28.6) 1020 (23.8) 88 (50.3) 753 (43.6)
Area of residence
Metropolitan 2147 (90.5) 2153 (50.3) ,0.001 156 (89.1) 843 (48.8) ,0.001
Urban 195 (8.2) 1638 (38.2) 16 (9.1) 653 (37.8)
Rural 31 (1.3) 494 (11.5) 3 (1.7) 231 (13.4)
Socioeconomic statusb
Quartile 1 121 (5.1) 199 (4.6) 0.129 10 (5.7) 137 (7.9) 0.368
Quartile 2 1189 (50.1) 2265 (52.9) 96 (54.9) 833 (48.2)
Quartile 3 464 (19.6) 828 (19.3) 27 (15.4) 300 (17.4)
Quartile 4 599 (25.2) 993 (23.2) 42 (24.0) 457 (26.5)
CVD, cardiovascular disease; DM, diabetes mellitus.
aThe difference between suicide completers’ family members and the comparison group. A x2 test was used.
bQuartile 1 is the lowest; all quartiles are based on the health insurance premium rate grade.
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in haemodynamics related to cardiovascular risk factors.22 In add-
ition, behavioural changes after bereavement, such as alcohol con-
sumption, could contribute to the increased risks of CVD.6,23
Previous research has suggested an increased risk for myocardial in-
farction within 1 day of the death of a significant other for patients
with a past history of myocardial infarction.14 In our study, among
those with a past history of CVD, DM, or psychiatric disorders, sui-
cide completers’ family members showed a decrease in the number
of medical care visits after a suicide loss and were at lower risk of
hospitalization for CVD during the subsequent year compared
with the non-bereaved. This implies that suicide completers’ family
members with underlying CVD had fewer opportunities to detect
or treat disease exacerbation, which might be linked to an increased
risk of cardiovascular death in the long term. Many studies have
shown that the bereaved are at the highest risk for death during
the 6 months after a family loss, but the risk remains high for several
years.24 We could not observe any significance for mortality due to
the small sample size (12 deaths), so additional research that in-
cludes a larger sample size and a longer term follow-up period is
necessary.
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Table 2 Changes in the number of medical care visits among suicide completers’ family members, separated by a past
history of cardiovascular disease, diabetes mellitus, or psychiatric disordersa
Without a past history of CVD, DM, or
psychiatric disorders
With a past history of CVD, DM, or psychiatric
disorders
Before suicide loss After suicide loss Before suicide loss After suicide loss
Men, n (%)
Total 1.0 (0.0–2.0) 2.0 (0.0–6.0) 6.0 (4.0–12.0) 3.0 (0.0–9.0)
Age (years)
40–49 1.0 (0.0–2.0) 1.0 (0.0–4.0) 5.0 (3.0–8.0) 1.0 (0.0–7.0)
50–64 1.0 (0.0–1.0) 2.0 (0.0–7.0) 6.0 (3.0–10.0) 3.0 (0.0–8.0)
≥65 1.0 (0.0–2.0) 4.0 (0.0–9.0) 9.0 (4.5–19.5) 3.0 (0.0–11.5)
Area of residence
Metropolitan 1.0 (0.0–2.0) 2.0 (0.0–6.0) 6.0 (3.0–11.0) 3.0 (0.0–8.0)
Urban 1.0 (0.0–1.0) 2.0 (0.0–6.0) 7.5 (4.0–18.0) 3.5 (0.0–13.0)
Rural 1.0 (0.0–3.0) 2.0 (1.0–8.0) 6.0 (5.0–16.0) 2.0 (0.0–5.0)
Socioeconomic statusb
Quartile 1 1.0 (0.0–1.0) 2.0 (0.0–6.0) 8.0 (4.0–20.0) 3.0 (1.0–5.0)
Quartile 2 1.0 (0.0–2.0) 2.0 (0.0–6.0) 6.0 (3.0–10.0) 3.5 (0.0–10.0)
Quartile 3 1.0 (0.0–1.0) 2.0 (0.0–7.0) 6.5 (2.0–15.0) 1.0 (0.0–7.0)
Quartile 4 1.0 (0.0–1.0) 2.0 (0.0–6.0) 7.0 (5.0–15.0) 2.0 (0.0–9.0)
Women, n (%)
Total 1.0 (0.0–2.0) 3.0 (0.0–9.0) 6.0 (3.0–10.0) 5.0 (0.0–11.0)
Age (years)
40–49 1.0 (0.0–2.0) 3.0 (0.0–7.0) 5.0 (2.0–6.0) 6.5 (1.5–10.5)
50–64 1.0 (0.0–2.0) 4.0 (0.0–10.0) 6.0 (3.0–8.0) 6.0 (1.0–13.0)
≥65 1.0 (0.0–2.0) 4.0 (0.0–9.0) 7.0 (3.0–13.0) 4.0 (0.0–10.0)
Area of residence
Metropolitan 1.0 (0.0–2.0) 3.0 (0.0–9.0) 6.0 (3.0–10.5) 5.5 (0.0–10.5)
Urban 1.0 (0.0–2.0) 3.0 (0.0–8.0) 6.0 (3.0–8.0)c 4.0 (0.0–13.0)c
Rural 0.0 (0.0–2.0) 5.0 (1.0–11.0)
Socioeconomic statusb
Quartile 1 1.0 (0.0–1.0) 4.0 (0.0–11.0) 5.5 (2.0–10.0) 2.0 (0.0–6.0)
Quartile 2 1.0 (0.0–2.0) 3.0 (0.0–9.0) 6.0 (3.0–9.5) 6.0 (1.0–10.5)
Quartile 3 1.0 (0.0–2.0) 3.0 (0.0–9.0) 8.0 (4.0–17.0) 4.0 (0.0–15.0)
Quartile 4 1.0 (0.0–2.0) 4.0 (0.0–8.0) 6.0 (3.0–11.0) 5.0 (0.0–13.0)
CVD, cardiovascular disease; DM, diabetes mellitus.
aThe number of inpatient or outpatient medical care visits was expressed as a median (25–75%).
bQuartile 1 is the lowest and is based on the health insurance premium rate grade.
cFor women, urban (n ¼ 16) and rural areas (n ¼ 3) of residence were combined due to low sample sizes.
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In the present study, we did not find a significant increase in the
risk of hospitalization for ischaemic heart disease and stroke among
suicide completers’ family members, except for hypertensive dis-
ease in both groups with and without a past history. This might be
related to insufficient statistical power due to a relatively small sam-
ple size and a short follow-up period. An additional follow-up study
would be helpful in determining the impact of suicide loss on the
cardiovascular system.
Diabetes mellitus
A previous non-specific bereavement study showed that parents
who had lost a child had approximately twice as high a risk of hos-
pitalization for type 2 DM.16 The current study is consistent with
that finding for subjects who did not have a past history of DM,
although suicide loss may induce more severe psychological stress
than typical bereavement.17,25 Several studies have reported that
psychological stress from suicide loss develops or worsens the
symptoms of DM through an increase in the levels of fasting blood
glucose and stress hormones such as cortisol.26,27 Thus, it is plaus-
ible that suicide completers’ family members who have had impaired
glucose tolerance or undiagnosed DM might develop DM after a sui-
cide loss, resulting in hospitalization. In the current study, the risk of
recurrent hospitalizations for DM during the year after a suicide loss
was lower than that for the first hospitalization. This might be be-
cause there were more individuals with more than two hospitaliza-
tions for DM in the comparison group. Because aggravation of DM is
preventable by early detection and regular follow-up care, constant
medical attention or supportive care might be necessary, especially
among the elderly who have experienced a suicide loss.
Strengths and limitations
In previous studies on suicide loss, suicide completers’ family mem-
bers were recruited by advertisement or phone,7,8 and 33 and 67%,
respectively, of individuals agreed to participate. Selection bias may
have been a factor in those studies because negative cultural atti-
tudes towards mental illnesses2,28 make it difficult to recruit a rep-
resentative sample of suicide completers’ family members in Asian
countries. Thus, using medical care utilization data is a necessary
method for accessing information about suicide completers’ family
members and their health status. To our knowledge, this study is the
first to investigate the effect of suicide loss on the risk of hospitaliza-
tion for CVD, DM, and psychiatric disorders using representative
family members of both suicides and matched comparison indivi-
duals. Although we could not compare the effect of suicide loss
with that of non-suicidal loss on CVD and DM risks, our study ex-
poses the risk of cardiometabolic health in the management of indi-
viduals with suicide loss in family. However, there are several
limitations to this study. Because of the family-based sampling meth-
od, the baseline characteristics of each family member might not
have been controlled. In particular, there were differences in the dis-
tribution of area of residence between suicide completers’ family
members and the comparison group. However, the notable regional
inequality in access to medical care was not observed in this study,
which might be due to National Health Insurance in the Republic of
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Table 3 Hazard ratiosa (95% confidence intervals) for hospitalizations for cardiovascular disease, diabetes mellitus, and
psychiatric disorders after suicide loss, separated by a past history of any of these conditions
First eventb Recurrent eventsc
Men Women Men Women
Without a past history of CVD, DM, or psychiatric disorders
CVD 0.967 (0.675–1.387) 1.202 (0.944–1.531) 1.343 (1.001–1.800) 1.240 (1.025–1.500)
Hypertensive disease 1.226 (0.803–1.873) 1.382 (1.059–1.804) 1.475 (1.043–2.085) 1.321 (1.063–1.641)
Ischaemic heart disease 0.470 (0.189–1.169) 0.701 (0.328–1.497) 0.517 (0.240–1.112) 0.772 (0.446–1.339)
Stroke 0.674 (0.285–1.597) 0.906 (0.478–1.718) 0.694 (0.340–1.418) 0.877 (0.551–1.394)
DM 3.383 (1.715–6.673) 2.480 (1.489–4.129) 2.238 (1.379–3.632) 1.786 (1.263–2.527)
Psychiatric disorders 2.665 (1.495–4.750) 1.294 (0.916–1.827) 2.135 (1.425–3.198) 1.607 (1.229–2.101)
Any of diseases above 1.477 (1.117–1.952) 1.319 (1.088–1.599) 1.578 (1.267–1.966) 1.316 (1.134–1.528)
With a past history of CVD, DM, or psychiatric disorders
CVD 0.416 (0.254–0.683) 0.334 (0.224–0.497) 0.539 (0.382–0.762) 0.526 (0.406–0.681)
Hypertensive disease 0.391 (0.222–0.688) 0.320 (0.207–0.494) 0.463 (0.304–0.706) 0.464 (0.344–0.626)
Ischaemic heart disease 0.165 (0.022–1.253) 0.463 (0.142–1.508) 0.408 (0.108–1.543) 0.438 (0.135–1.417)
Stroke 0.875 (0.293–2.610) 0.617 (0.240–1.584) 1.055 (0.449–2.475) 0.612 (0.268–1.397)
DM 0.186 (0.075–0.460) 0.297 (0.138–0.640) 0.265 (0.128–0.551) 0.424 (0.240–0.749)
Psychiatric disorders 1.651 (0.822–3.317) 1.221 (0.693–2.153) 0.828 (0.492–1.395) 1.089 (0.704–1.685)
Any of diseases above 0.385 (0.259–0.573) 0.407 (0.299–0.554) 0.611 (0.485–0.770) 0.667 (0.556–0.800)
CVD, cardiovascular disease; DM, diabetes mellitus.
aHazard ratios refer to the risks among suicide completers’ family members, when compared with non-bereaved family members.
bFrom the Cox proportional hazard model, after adjustment for age, area of residence, and socioeconomic status.
cFrom the stratified Cox proportional hazard model with the PWP total time model, after adjustment for age, area of residence, and socioeconomic status.
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Korea.29 Thus, the difference in the distribution of area of residence
might not have distorted our results. Secondly, inaccuracy in the
diagnosis code from the health insurance claims data might lead
to misclassification bias. However, we considered hospital admis-
sion as an endpoint, which likely has high accuracy.30 –32 Owing to
the National Health Insurance in the Republic of Korea, almost all
hospital admissions for CVD, DM, and psychiatric disorder are cov-
ered, so collectively, misclassification bias might be non-differential.
We also identified past history of CVD, DM, or psychiatric disor-
ders, using health insurance claims data obtained 1 year before sui-
cide loss, leading to an underestimation of the true prevalence of
those illnesses. However, we applied the same period to the suicide
loss group and the comparison group, which minimizes bias in our
results. Thirdly, although a family-based sampling process was used
in order to minimize the effect of relationship (i.e. spouse, offspring,
and sibling) between suicide completers and family members, we
could not identify those relationships due to limitations in the
HIRA data. Thus, the relationship might act as an unmeasured con-
founder. However, the confounding effects of relationship might be
less likely to distort our results because psychological distress over
societal stigma of suicide might be amplified by family members’
age.33 In future studies, it is necessary to investigate the impact of
suicide loss on family members by the relationships with suicide
completers within a certain age group to develop targeting
strategies.
In conclusion, the present results suggest the adverse effect of
suicide loss on family members’ cardiometabolic health and indicate
a need to prevent CVD and DM after suicide loss.
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